Full Press Release Details
to present at NWR Virtual Healthcare Conference
Sydney, Australia- 19 March 2026 - Radiopharm Theranostics
(ASX: RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative
oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that it will present at the NWR Virtual Healthcare
CEO & Managing Director Riccardo Canevari will present at 8:30am
AEDT on Wednesday 25 March 2026.
Shareholders, investors and interested parties are encouraged to register
to attend the presentation at the following link: https://us02web.zoom.us/webinar/register/WN_WlOvxNAQRImgmoTV07BUsA
A recording will be available at the above link shortly after the conclusion
of the live session, and the replay will also be available via the Company's website and social media channels.
Questions can be submitted on the day or sent in advance to matt@nwrcommunications.com.au
For more information please visit: https://nwrcommunications.com/healthconf
About Radiopharm Theranostics
Radiopharm Theranostics is a clinical stage radiotherapeutics
company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas
of high unmet medical need. Radiopharm is listed on ASX (RAD) and on NASDAQ (RADX). The company has a pipeline of distinct and highly
differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program
includes one Phase 2 and four Phase 1 trials in a variety of solid tumor cancers including lung, breast, and brain metastases. Learn
more at radiopharmtheranostics.com.
Authorised on behalf of the Radiopharm Theranostics board of directors
by Chairman Paul Hopper.
For more information:
CEO & Managing Director
Radiopharm Theranostics
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
Precision AQ (Formerly Stern IR)
Radiopharm Theranostics
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia